Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans (Q33335176)

25 July 2017

title

Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans (English)

1 reference

25 July 2017

Salgado JV

1

1 reference

25 July 2017

Hetem LA

2

1 reference

25 July 2017

Vidal M

3

1 reference

25 July 2017

Graeff FG

4

1 reference

25 July 2017

Danion JM

5

1 reference

25 July 2017

Sandner G

6

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Behavioural Brain Research

25 July 2017

published in

1 reference

25 July 2017

volume

117

1 reference

25 July 2017

issue

1-2

1 reference

25 July 2017

page(s)

61-67

1 reference

Amphetamine response and relapse risk after depot neuroleptic discontinuation

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Decoupling motor memory strategies: effects of sleep deprivation and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Effects of parachlorophenylalanine and amphetamine on habituation of orienting

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Integrating schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Methylphenidate challenge as a predictor of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Latent inhibition as a measure of learned inattention: some problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Cocaine, kindling, and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Associative learning and latent inhibition in a conditioned suppression paradigm in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Neurochemical brain imaging investigations of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Latent inhibition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Effects of nicotine and amphetamine on latent inhibition in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Latent inhibition and autonomic responses: a psychophysiological approach

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Facilitation of latent inhibition by haloperidol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

The switching model of latent inhibition: an update of neural substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Haloperidol enhances latent inhibition in visual tasks in healthy people

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Autonomic nervous system activity in acute schizophrenia: II. relationships to short-term prognosis and clinical state.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

Cognitive skill learning and schizophrenia: implications for cognitive remediation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900279-5

7 January 2021

10.1016/S0166-4328(00)00279-5

Identifiers

DOI

1 reference

25 July 2017

1 reference